Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety

NCT02883374 is registered in ClinicalTrials.gov with Dong mei as lead sponsor.

NCT NCT02883374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02883374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety
Lead sponsor
Dong mei
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2016
Completion date
June 30, 2020
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocystic carcinoma